{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T07:26:07Z","timestamp":1788938767767,"version":"build-2803163510"},"reference-count":38,"publisher":"American Diabetes Association","issue":"4","license":[{"start":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T00:00:00Z","timestamp":1553040000000},"content-version":"vor","delay-in-days":55,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"name":"Anterogen"},{"name":"Ministry of Health & Welfare, Republic of Korea","award":["HI16C1037"],"award-info":[{"award-number":["HI16C1037"]}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,4,1]]},"abstract":"<jats:p>Mesenchymal stem cells (MSCs) may hold great promise for treating diabetic wounds. However, it is difficult for a clinician to use MSCs because they have not been commercialized. Meanwhile, a new commercial drug that contains adipose-derived stem cells (ASCs) has been developed. The purpose of this study was to examine the potential of allogeneic ASC sheets for treating diabetic foot ulcers. Fifty-nine patients with diabetic foot ulcers were randomized to either the ASC treatment group (n = 30) or a control group treated with polyurethane film (n = 29). Either an allogeneic ASC sheet or polyurethane film was applied on diabetic wounds weekly. These wounds were evaluated for a maximum of 12 weeks. Complete wound closure was achieved for 73% in the treatment group and 47% in the control group at week 8. Complete wound closure was achieved for 82% in the treatment group and 53% in the control group at week 12. The Kaplan-Meier median times to complete closure were 28.5 and 63.0 days for the treatment group and the control group, respectively. There were no serious adverse events related to allogeneic ASC treatment. Thus, allogeneic ASCs might be effective and safe to treat diabetic foot ulcers.<\/jats:p>","DOI":"10.2337\/db18-0699","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T19:45:36Z","timestamp":1548359136000},"page":"837-846","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":187,"title":["Potential of Allogeneic Adipose-Derived Stem Cell\u2013Hydrogel Complex for Treating Diabetic Foot Ulcers"],"prefix":"10.2337","volume":"68","author":[{"given":"Kyung-Chul","family":"Moon","sequence":"first","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Korea University Guro Hospital, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Suk","family":"Suh","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Asan Medical Center, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Bum","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Korea University Guro Hospital, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2875-9276","authenticated-orcid":false,"given":"Seung-Kyu","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Korea University Guro Hospital, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Won","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Foot and Ankle Surgery, Eulji Medical Center, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0293-9017","authenticated-orcid":false,"given":"Jin-Woo","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0293-9017","authenticated-orcid":false,"given":"Mi-Hyung","family":"Kim","sequence":"additional","affiliation":[{"name":"Anterogen Co. Ltd., Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"key":"2022031303382959900_B1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0094-1298(02)00073-1","article-title":"Cytokine manipulation of the wound","volume":"30","author":"Robson","year":"2003","journal-title":"Clin Plast Surg"},{"key":"2022031303382959900_B2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/01.sap.0000178809.01289.10","article-title":"Potential of human bone marrow stromal cells to accelerate wound healing in vitro","volume":"55","author":"Han","year":"2005","journal-title":"Ann Plast Surg"},{"key":"2022031303382959900_B3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C","article-title":"Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells","volume":"181","author":"Conget","year":"1999","journal-title":"J Cell Physiol"},{"key":"2022031303382959900_B4","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.bjps.2009.04.006","article-title":"Effect of human bone marrow stromal cell allograft on proliferation and collagen synthesis of diabetic fibroblasts in vitro","volume":"63","author":"Kim","year":"2010","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"2022031303382959900_B5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/SAP.0b013e318036aadf","article-title":"Effect of human bone marrow stromal cells and dermal fibroblasts on collagen synthesis and epithelization","volume":"59","author":"Lee","year":"2007","journal-title":"Ann Plast Surg"},{"key":"2022031303382959900_B6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/01.prs.0000201458.80364.31","article-title":"The effect of human bone marrow stromal cells and dermal fibroblasts on angiogenesis","volume":"117","author":"Han","year":"2006","journal-title":"Plast Reconstr Surg"},{"key":"2022031303382959900_B7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4252\/wjsc.v9.i8.107","article-title":"Adipose-derived stromal cell in regenerative medicine: a review","volume":"9","author":"Tabatabaei Qomi","year":"2017","journal-title":"World J Stem Cells"},{"key":"2022031303382959900_B8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13287-017-0598-y","article-title":"Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation","volume":"8","author":"Bora","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"2022031303382959900_B9","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jcyt.2016.06.008","article-title":"Adipose mesenchymal stromal cells minimize and repair radiation-induced oral mucositis","volume":"18","author":"Maria","year":"2016","journal-title":"Cytotherapy"},{"key":"2022031303382959900_B10","doi-asserted-by":"crossref","first-page":"9328347","DOI":"10.1155\/2017\/9328347","article-title":"Mesenchymal stem cells improve healing of diabetic foot ulcer","volume":"2017","author":"Cao","year":"2017","journal-title":"J Diabetes Res"},{"key":"2022031303382959900_B11","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.2337\/db14-1133","article-title":"Allogeneic transplantation of an adipose-derived stem cell sheet combined with artificial skin accelerates wound healing in a rat wound model of type 2 diabetes and obesity","volume":"64","author":"Kato","year":"2015","journal-title":"Diabetes"},{"key":"2022031303382959900_B12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4161\/org.24946","article-title":"The use of adipose-derived stem cells as sheets for wound healing","volume":"9","author":"McLaughlin","year":"2013","journal-title":"Organogenesis"},{"key":"2022031303382959900_B13","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1524-475X.2012.00809.x","article-title":"Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes\u2014a pilot study","volume":"20","author":"You","year":"2012","journal-title":"Wound Repair Regen"},{"key":"2022031303382959900_B14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/iwj.12329","article-title":"The efficacy and safety of Grafix for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial","volume":"11","author":"Lavery","year":"2014","journal-title":"Int Wound J"},{"key":"2022031303382959900_B15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3758\/s13428-014-0490-y","article-title":"The stochastically curtailed generalized likelihood ratio: a new termination criterion for variable-length computerized classification tests","volume":"47","author":"Huebner","year":"2015","journal-title":"Behav Res Methods"},{"key":"2022031303382959900_B16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/archderm.134.3.293","article-title":"Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent","volume":"134","author":"Falanga","year":"1998","journal-title":"Arch Dermatol"},{"key":"2022031303382959900_B17","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1097\/00007890-199906270-00014","article-title":"The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection","volume":"67","author":"Briscoe","year":"1999","journal-title":"Transplantation"},{"key":"2022031303382959900_B18","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2337\/diacare.26.6.1701","article-title":"The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial","volume":"26","author":"Marston","year":"2003","journal-title":"Diabetes Care"},{"key":"2022031303382959900_B19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7547\/1000073","article-title":"Confirmatory data from EU study supports Apligraf for the treatment of neuropathic diabetic foot ulcers","volume":"100","author":"Steinberg","year":"2010","journal-title":"J Am Podiatr Med Assoc"},{"key":"2022031303382959900_B20","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1097\/01.PRS.0000142415.57470.DF","article-title":"Clinical application of fresh fibroblast allografts for the treatment of diabetic foot ulcers: a pilot study","volume":"114","author":"Han","year":"2004","journal-title":"Plast Reconstr Surg"},{"key":"2022031303382959900_B21","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1524-4725.2009.01239.x","article-title":"Efficacy and safety of fresh fibroblast allografts in the treatment of diabetic foot ulcers","volume":"35","author":"Han","year":"2009","journal-title":"Dermatol Surg"},{"key":"2022031303382959900_B22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1524-475X.1998.60207.x","article-title":"Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of l-lactate","volume":"6","author":"Hehenberger","year":"1998","journal-title":"Wound Repair Regen"},{"key":"2022031303382959900_B23","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jcyt.2017.03.074","article-title":"Effects of human umbilical cord blood-derived mesenchymal stromal cells and dermal fibroblasts on diabetic wound healing","volume":"19","author":"Moon","year":"2017","journal-title":"Cytotherapy"},{"key":"2022031303382959900_B24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3346\/jkms.2014.29.3.311","article-title":"Cell therapy for wound healing","volume":"29","author":"You","year":"2014","journal-title":"J Korean Med Sci"},{"key":"2022031303382959900_B25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jss.2017.04.032","article-title":"Adipose-derived stem cells seeded in Pluronic F-127 hydrogel promotes diabetic wound healing","volume":"217","author":"Kaisang","year":"2017","journal-title":"J Surg Res"},{"key":"2022031303382959900_B26","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s12033-014-9735-3","article-title":"Transplantation of mesenchymal cells improves peripheral limb ischemia in diabetic rats","volume":"56","author":"Madonna","year":"2014","journal-title":"Mol Biotechnol"},{"key":"2022031303382959900_B27","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/wrr.12051","article-title":"Diabetes impairs adipose tissue-derived stem cell function and efficiency in promoting wound healing","volume":"21","author":"Cianfarani","year":"2013","journal-title":"Wound Repair Regen"},{"key":"2022031303382959900_B28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5966\/sctm.2012-0041","article-title":"Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stem\/progenitor cells","volume":"2","author":"Shin","year":"2013","journal-title":"Stem Cells Transl Med"},{"key":"2022031303382959900_B29","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(05)67700-8","article-title":"Wound healing and its impairment in the diabetic foot","volume":"366","author":"Falanga","year":"2005","journal-title":"Lancet"},{"key":"2022031303382959900_B30","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0140-6736(05)67698-2","article-title":"The global burden of diabetic foot disease","volume":"366","author":"Boulton","year":"2005","journal-title":"Lancet"},{"key":"2022031303382959900_B31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/wound.2014.0571","article-title":"Quality randomized clinical trials of topical diabetic foot ulcer healing agents","volume":"5","author":"Bolton","year":"2016","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"2022031303382959900_B32","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2337\/diacare.24.2.290","article-title":"Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial","volume":"24","author":"Veves","year":"2001","journal-title":"Diabetes Care"},{"key":"2022031303382959900_B33","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/iwj.12954","article-title":"Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: a prospective, randomised, multi-centre clinical trial in 80 patients","volume":"15","author":"DiDomenico","year":"2018","journal-title":"Int Wound J"},{"key":"2022031303382959900_B34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/iwj.12976","article-title":"A confirmatory study on the efficacy of dehydrated human amnion\/chorion membrane dHACM allograft in the management of diabetic foot ulcers: a prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics","volume":"16","author":"Tettelbach","year":"2019","journal-title":"Int Wound J"},{"key":"2022031303382959900_B35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.diabres.2018.06.002","article-title":"Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: a phase III multicenter, double-blind, randomized, placebo-controlled trial","volume":"142","author":"Park","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031303382959900_B36","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1524-475X.2010.00593.x","article-title":"The treatment of diabetic foot ulcers with uncultured, processed lipoaspirate cells: a pilot study","volume":"18","author":"Han","year":"2010","journal-title":"Wound Repair Regen"},{"key":"2022031303382959900_B37","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing\u2014when and how","volume":"54","author":"Bender","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"2022031303382959900_B38","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/1745-6215-15-364","article-title":"Correcting for multiple-testing in multi-arm trials: is it necessary and is it done","volume":"15","author":"Wason","year":"2014","journal-title":"Trials"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/68\/4\/837\/523526\/db180699.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/68\/4\/837\/523526\/db180699.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T05:38:36Z","timestamp":1720935516000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/68\/4\/837\/39767\/Potential-of-Allogeneic-Adipose-Derived-Stem-Cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,1,24]]},"published-print":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db18-0699","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]}}}